Matthias von Herrath

Company: Novo Nordisk
Job title: VP & Senior Medical Officer
Seminars:
Panel Discussion: Improving Strategies for Long Term Graft Acceptance of Allogeneic Therapies 11:30 am
Exploring the regulations around how cells can be modified How much do you need to modify cells? Moving towards improving immune modulatory regimens that don’t require long-term immune suppressionRead more
day: Day Two